Mergers & Acquisitions - Mergers & Acquisitions, Generics, Biotechnology

2012 again a bumper year for Pharma M&A, but values well down

09-01-2013

The year 2012 was again a bumper year for merger and acquisition activity in the global pharmaceutical,…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2012

07-01-2013

Details for the 131 M&A announcements in 2012 recorded by The Pharma Letter are provided in the full…

BiotechGenericsMergers & AcquisitionsPharmaceutical

Questcor Pharmaceuticals to acquire BioVectra for around $50 million

04-01-2013

California, USA-based Questcor Pharmaceuticals (Nasdaq: QCOR) has signed a definitive agreement to acquire…

BiotechnologyBioVectraGenericsMergers & AcquisitionsPharmaceuticalProductionQuestor Pharmaceuticals

Canada's Pharmascience sets up JV with Korea Kolmar; buys Rivex

03-01-2013

Privately-held Canadian drugmaker Pharmascience and Korea Kolmar Holdings, based in Seoul, South Korea,…

Asia-PacificBiotechnologyGenericsHelix BioPharmaKorea KolmarMergers & AcquisitionsNeurologicalNorth AmericaPharmaceuticalPharmascienceRivex Pharma

American Capital commits $212 million to acquire Cambridge Major Laboratories

03-01-2013

Private equity firm American Capital (Nasdaq: ACAS) says that it has committed $212 million in the buyout…

American CapitalBiotechnologyCambridge Major LaboratoriesGenericsMergers & AcquisitionsPharmaceutical

Sanofi buys Colombian drugmaker; Presents encouraging eliglustat and Lyxumia data; Revizes deal with B-MS

03-10-2012

In what turns out to be a very busy couple of days for French drug major Sanofi (Euronext: SAN), the…

AvaproBiotechnologyBristol-Myers SquibbCardio-vascularDiabeteseliglustatGenericsGenfar SAGlobalLyxumiaMarkets & MarketingMergers & AcquisitionsPharmaceuticalPlavixRare diseasesResearchSanofiSouth America

China's BGI-Shenzhen to acquire Complete Genomics; Mitsui ups stake in Arch Pharmalabs

18-09-2012

Complete Genomics (Nasdaq: GNOM) yesterday revealed that it has entered into a definitive merger agreement…

Arch PharmalabsBGI-ShenzhenBiotechnologyComplete GenomicsGenericsMergers & AcquisitionsMitsui & Co

News briefs: Roche's dalcetrapib; Coherus/Daiichi deal; Mercury Pharma; AEterna Zentaris

08-05-2012

Swiss drug major Roche (ROG: SIX) saw its shares drop 4.5% to 159.30 Swiss francs by around midday yesterday,…

AEterna ZentarisBiotechnologyCoherus BioSciencesDaiichi SankyodalcetrapibGenericsKeryx BiopharmaceuticalsLicensingMercury PharmaMergers & AcquisitionsperifosinePharmaceuticalResearchRoche

Kyowa Hakko sets up biosimilars joint venture with Fujifilm

29-03-2012

Japanese digital camera and medical equipment conglomerate Fujifilm and drugmaker Kyowa Hakko Kirin have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyFujifilm Kyowa Kirin BiologicsGenericsHumiraKyowa Hakko KirinMergers & AcquisitionsResearch

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

29-03-2012

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

2011 a bumper year for Pharma, Biotech and Generics M&A

11-01-2012

Although there were few multi-billion dollar deals, 2011 turned into a bumper year for the number of…

BiotechBiotechnologyGenericsMergers & AcquisitionsPharmaceutical

Pharmaceutical M&A deals in 2011

11-01-2012

Details for the 129 M&A announcements recorded by The Pharma Letter are provided in the full table

BiotechGenericsMergers & AcquisitionsPharmaceutical

Back to top